CAAS Capital Management’s Gyre Therapeutics GYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-20,769	Closed	-$670K	–	522
2020 Q3	$670K	Sell	20,769 -26,900	-56%	-$868K	0.02%	208
2020 Q2	$2.1M	Buy	+47,669	New	+$2.1M	0.07%	88